NanoString Technologies, Inc. (NSTG) financial statements (2022 and earlier)

Company profile

Business Address 530 FAIRVIEW AVENUE NORTH
SEATTLE, WA 98109
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments348,889440,731146,33724,35677,55574,03649,044
Cash and cash equivalents107,068411,84829,03324,35626,13620,58321,856
Short-term investments241,82128,883117,304 51,41953,45327,188
Receivables40,13031,10027,15317,27919,56422,37919,725
Inventory, net of allowances, customer advances and progress billings31,48622,95919,78113,17320,05713,81210,138
Inventory31,48622,95919,78113,17320,05713,81210,138
Prepaid expense     328314
Deferred costs      181
Deposits current assets     1,2621,664
Other undisclosed current assets7,1154,19019,33676,8994,7451,9681,727
Total current assets:427,620498,980212,607131,707121,921113,78582,793
Noncurrent Assets
Operating lease, right-of-use asset19,22621,49224,648
Property, plant and equipment27,04320,82820,18415,17114,05712,1589,414
Restricted cash and investments    143143143
Other noncurrent assets5,5922,8952,315680641287338
Other undisclosed noncurrent assets      181
Total noncurrent assets:51,86145,21547,14715,85114,84112,58810,076
TOTAL ASSETS:479,481544,195259,754147,558136,762126,37392,869
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities38,51425,54530,83424,40117,23317,27915,424
Accounts payable14,2835,31310,2828,6364,0924,9353,243
Accrued liabilities6,7654,9704,9733,7054,50712,34412,181
Employee-related liabilities17,46615,26215,57912,0608,634  
Deferred revenue7,4745,6103,997
Debt  3,766  58226
Deferred rent credit   657
Deferred revenue and credits9,74119,0465,261
Customer advances and deposits8,945  
Other undisclosed current liabilities6,1675,9446,38918,057   
Total current liabilities:52,15537,09944,98643,11535,91936,38320,911
Noncurrent Liabilities
Long-term debt and lease obligation, including:225,144172,70379,95158,39648,93147,36641,000
Operating lease, liability21,69325,60229,368
Other undisclosed long-term debt and lease obligation203,451147,10150,58358,39648,93147,36641,000
Liabilities, other than long-term debt3,5271,8439768,2003,30430,16410,743
Deferred revenue and credits3,30430,16410,743
Deferred revenue3,5271,843976
Deferred rent credit   8,200
Other undisclosed noncurrent liabilities21,69325,60229,6909788,499155 
Total noncurrent liabilities:250,364200,148110,61767,57460,73477,68551,743
Total liabilities:302,519237,247155,603110,68996,653114,06872,654
Stockholders' equity
Stockholders' equity attributable to parent176,962306,948104,15136,86940,10912,30520,215
Common stock5443222
Additional paid in capital827,028848,891535,954428,162353,308281,900242,693
Accumulated other comprehensive income (loss)(318)83145(40)(99)(57)(29)
Accumulated deficit(649,753)(542,030)(431,952)(391,256)(313,102)(269,540)(222,451)
Total stockholders' equity:176,962306,948104,15136,86940,10912,30520,215
TOTAL LIABILITIES AND EQUITY:479,481544,195259,754147,558136,762126,37392,869

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues145,085117,316125,568106,732114,90586,48962,667
Revenue, net72,01069,13456,639
Cost of revenue(68,304)(52,409)(44,039)(36,331)(31,880)(30,245)(26,126)
Gross profit:76,78164,90781,52970,40183,02556,24436,541
Operating expenses(185,007)(152,954)(164,230)(139,794)(121,222)(97,420)(77,783)
Operating loss:(108,226)(88,047)(82,701)(69,393)(38,197)(41,176)(41,242)
Nonoperating income (expense)(6,861)(21,778)42,274(7,758)(5,161)(5,797)(4,173)
Investment income, nonoperating6491,744(5,668)(6,100)(5,344)(5,282)(3,784)
Other nonoperating income (expense)(20)(971)(929)(1,658)183(515)(389)
Interest and debt expense(7,500)(7,143) (842)   
Loss from continuing operations before equity method investments, income taxes:(122,587)(116,968)(40,427)(77,993)(43,358)(46,973)(45,415)
Other undisclosed income from continuing operations before income taxes7,5007,143 842   
Loss from continuing operations before income taxes:(115,087)(109,825)(40,427)(77,151)(43,358)(46,973)(45,415)
Income tax expense(167)(253)(269)(249)(204)(116)(166)
Net loss available to common stockholders, diluted:(115,254)(110,078)(40,696)(77,400)(43,562)(47,089)(45,581)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(115,254)(110,078)(40,696)(77,400)(43,562)(47,089)(45,581)
Other comprehensive income (loss)(401)(62)18559(42)(28)14
Comprehensive loss, net of tax, attributable to parent:(115,655)(110,140)(40,511)(77,341)(43,604)(47,117)(45,567)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: